Get started
Author

Xuwei Shao

Observed name: Shao, Xuwei
ORCID: 0000-0002-7166-4045
Observed ORCID: 0000-0002-7166-4045
OpenAlex ID: A5003914820
Design and Synthesis of Poly(ADP-ribose) Polymerase Inhibitors: Impact of Adenosine Pocket-Binding Motif Appendage to the 3-Oxo-2,3-dihydrobenzofuran-7-carboxamide on Potency and Selectivity
2019 · Uday Kiran Velagapudi, Marie-France Langelier, et al. · Journal of Medicinal Chemistry · 50
Chemical Space Exploration around Thieno[3,2-d]pyrimidin-4(3H)-one Scaffold Led to a Novel Class of Highly Active Clostridium difficile Inhibitors
2019 · Xuwei Shao, Ahmed AbdelKhalek, et al. · Journal of Medicinal Chemistry · 37
Recent development in the discovery of PARP inhibitors as anticancer agents: a patent update (2016-2020)
2021 · Uday Kiran Velagapudi, Bhargav A. Patel, et al. · Expert Opinion on Therapeutic Patents · 24
Synthesis of 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxamide and 3-oxo-3,4-dihydrobenzo[b][1,4]oxazine-8-carboxamide derivatives as PARP1 inhibitors
2020 · Xuwei Shao, Steven Pak, et al. · Bioorganic Chemistry · 12
Novel modifications of PARP inhibitor veliparib increase PARP1 binding to DNA breaks
2024 · Uday Kiran Velagapudi, Élise Rouleau-Turcotte, et al. · Biochemical Journal · 6
Long-term outcomes of eltrombopag plus cyclosporine A in eltrombopag-exposed patients with glucocorticoid-resistant or -dependent primary immune thrombocytopenia: a prospective, multicenter, single-arm, phase II study with extended follow-up
2026 · Yuhui Yuan, Jie Jin, et al. · Frontiers in Immunology
PDF
CCDC 1884213: Experimental Crystal Structure Determination
2019 · Shao, Xuwei, AbdelKhalek, Ahmed, et al. · The Cambridge Structural Database
Works count: 7
Citation count: 129
H-index: 5
I10-index: 4
Year
Topic
Type